These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 349596)

  • 21. Clozapine efficacy in schizophrenic nonresponders.
    Conley RR; Schulz SC; Baker RW; Collins JF; Bell JA
    Psychopharmacol Bull; 1988; 24(2):269-74. PubMed ID: 3212161
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of clozapine.
    Leon CA
    Arch Gen Psychiatry; 1978 Jul; 35(7):905. PubMed ID: 354553
    [No Abstract]   [Full Text] [Related]  

  • 23. Our experience with clozapine treatment.
    Molcan J; Novotný V; Schulpková L
    Act Nerv Super (Praha); 1974 Aug; 16(3):200-1. PubMed ID: 4153762
    [No Abstract]   [Full Text] [Related]  

  • 24. [An analysis of 106 cases of schizophrenia treated with clozapine].
    Yang JS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):242-4. PubMed ID: 6536459
    [No Abstract]   [Full Text] [Related]  

  • 25. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.
    Shopsin B; Klein H; Aaronsom M; Collora M
    Arch Gen Psychiatry; 1979 Jun; 36(6):657-64. PubMed ID: 375865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
    Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ
    Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term clozapine treatment of schizophrenic type psychoses and the significance of side-effects (author's transl)].
    Zapletálek M; Preiningerová O; Pazdirek S; Hanus H; Stránský P
    Cesk Psychiatr; 1977 Apr; 73(2):73-80. PubMed ID: 880672
    [No Abstract]   [Full Text] [Related]  

  • 29. Clozapine in the treatment of schizophrenic patients: an international multicenter trial.
    Panteleeva GP; Kovskaya MY; Belyaev BS; Minsker EI; Vynar O; Ceskova E; Svetska J; Libiger J; Korinkova V; Novotny V
    Clin Ther; 1987; 10(1):57-68. PubMed ID: 3329966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of clozapine. A follow-up study].
    Wojdyslawska I; Góraj A; Soczyńska J
    Psychiatr Pol; 1976; 10(5):497-502. PubMed ID: 981423
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of therapeutic effect of clozapin and chlorpromazin (author's transl)].
    Vencovský E; Peterová E; Baudis P
    Cesk Psychiatr; 1975 Jan; 71(1):21-6. PubMed ID: 1093729
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of the strength, homogeneity and consistency of the neuroleptic clozapine in a group of hospitalized schizophrenics].
    Molcan J; Korínková V; Novotný V; Zucha I
    Cesk Psychiatr; 1988 Jun; 84(3):168-72. PubMed ID: 3409363
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: The relation between the clinical effect of clozapine and the incidence of side effects.
    Marecek P; Dolezalová V; Faltus F
    Act Nerv Super (Praha); 1975; 17(4):221-2. PubMed ID: 1221762
    [No Abstract]   [Full Text] [Related]  

  • 34. Experience with the reduction of maintenance doses of clozapine and monitoring of its blood levels.
    Cesková E; Svestka J; Náhunek K; Rysánek R; Kolácný I
    Act Nerv Super (Praha); 1989 Jun; 31(2):118-9. PubMed ID: 2800943
    [No Abstract]   [Full Text] [Related]  

  • 35. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine: guidelines for clinical management.
    Lieberman JA; Kane JM; Johns CA
    J Clin Psychiatry; 1989 Sep; 50(9):329-38. PubMed ID: 2670914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.
    Matz R; Rick W; Thompson H; Gershon S
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):687-95. PubMed ID: 4210458
    [No Abstract]   [Full Text] [Related]  

  • 38. Clozapin in psychomotor instability. A controlled study.
    Výborová L; Náhunek K; Balastíková B; Misurec J
    Act Nerv Super (Praha); 1978 Dec; 20(4):274-5. PubMed ID: 367039
    [No Abstract]   [Full Text] [Related]  

  • 39. Clozapine in China: a review and preview of US/PRC collaboration.
    Potter WZ; Ko GN; Zhang LD; Yan WW
    Psychopharmacology (Berl); 1989; 99 Suppl():S87-91. PubMed ID: 2682733
    [No Abstract]   [Full Text] [Related]  

  • 40. Results of the long term treatment with clozapine. Clinical and electroencephalographic study.
    Zapletálek M; Hanus H; Kucera V; Kuba M
    Act Nerv Super (Praha); 1989 Apr; 31(1):36-7. PubMed ID: 2571221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.